Su et al. [35] |
2014 |
China |
Cross-sectional |
149 |
Pregnant women in first trimester who were seeking induced abortion |
Power-line MFs |
Maternal exposure to magnetic fields ≥0.82 mG and <0.82 mG |
Embryonic sac length ≤25th percentile (20 mm) (N = 36); >25th percentile (N = 94) |
OR: 1.56 (0.7–3.48) |
5 |
Embryonic bud length ≤25th percentile (7 mm) (N = 19); >25th percentile (N = 46) |
OR: 3.95 (1.10–14.20) |
Mahram and Ghazavi [11] |
2013 |
Iran |
Cohort |
380 |
Pregnant women and their newborns |
High-voltage power lines |
Maternal exposure during pregnancy to high-voltage power lines or living at a distance of 25 m from cables or high-voltage towers (mean MF: 3.0104 ± 1,081 mG) N = 222 vs unexposed group (mean MF: 0.419 ± 0.04 mG) N = 158 |
Congenital malformation |
1.43 (0.35 to 5.83) |
6 |
Sadeghi et al. [37] |
2017 |
Iran |
Nested case–control |
304 |
Case: the mothers with spontaneous preterm childbirth (N = 152); control: the mothers with tern childbirth |
High-voltage power lines or statin |
Maternal exposure during pregnancy to high-voltage power lines or living at a distance of 600 m from cables or high voltage towers N = 28 (9.8%) vs unexposed group (≥600 m) N = 257 (90.2%) |
Congenital malformation |
5.05 (1.52–16.78) |
|
Blaasaas et al. [34] |
2002 |
Norway |
Population-based study |
836,475 |
Records of the pregnant women that registered in Medical Birth of Norway |
Occupational exposure to 50 Hz EMF (melting industry, welders, machinists, pilots, some occupations in textile industries, woodworking factories, working with electricity, glass, and ceramics) |
Occupational exposure maternity to magnetic fields above 0.1 μT ≥ 24 h/week vs < 4 h/week) (0.1 µT = 1 mG) |
Case: all CNS defect (N = 1,171); control group (N = 777,039) |
OR: 1.41 (0.81–2.44) |
6 |
Case: spina bifida (N = 409): control group (N = 777,801) |
OR: 2.33 (1.10–4.94) |
Tabrizi and Bidgoli [30] |
2015 |
Iran |
Case–control |
122 |
Children diagnose with ALL and normal children <12 years |
Residence near high-voltage power lines |
Neonatal and childhood exposure to high voltage power lines (>4 yeras) by questionnaire |
Case group: childhood ALL (N = 22); control group: healthy children (N = 100) |
3.65 (1.69–7.87) |
4 |
Zarei et al. [38] |
2019 |
Iran |
Case–control |
185 |
Mothers of children aged 3–7 year diagnosed with speech problems and mothers of healthy children |
Residence near high-voltage power lines |
Maternal exposure to high-tension power line before pregnancy by questionnaire |
Case group: children with speech problems (N = 110); control group: healthy children (N = 75) |
18.96 (1.11–325.49) |
5 |
Maternal exposure to high-tension power lines during pregnancy by questionnaire |
4.34 (1.22–15.38) |
Lerman et al. [36] |
2001 |
Israel |
Case–control |
434 Women with 933 pregnancies |
Female physiotherapists who had ever been pregnant |
Occupational exposure to 27.12 MHz EMF (shortwaves and ultrasonic device) |
Occupational exposure of physiotherapist mothers to shortwaves device vs unexposed group |
Case: congenital malformation (N = 41); control group (N = 512) |
2.24 (1.28–4.83) |
5 |
Occupational exposure of physiotherapist mothers to ultrasonic device vs unexposed group |
Case: congenital malformation (N = 40); control group (N = 633) |
3.23 (1.5–8.68) |
Hug et al. [40] |
2010 |
German |
Case–control |
4,431 |
Children 0–14 years old with and without childhood cancer |
Occupational exposures: metal workers, electric welders, locomotive engineers, and power plant operators |
Fathers’ pre-conception exposure to EMFs ≤0.2 μT and >0.2 μT (0.2 µT = 2 mG) |
Case: children with cancer (N = 2,049); control group: healthy children (N = 2,382) |
1.03 (0.83–1.18) |
6 |
Ha et al. [39] |
2007 |
South Korean |
Case–control |
1,928 |
Children under age 15 years with leukemia |
Radio transmitter (with a power of 20 kW or more) |
Residence address <2 km from the nearest radio transmitter vs who was living >20 km from it |
Case: children with leukemia (N = 808); control group (N = 676) |
2.5 (1–4.67) |
5 |
Q1: <518.41 mV/m |
Lymphocytic leukemia (case: 514 vs control: 513) |
1 |
Q2: 518.41–<624.35 mV/m |
1.39 (1.04–1.86) |
Q3: 624.35–<916.96 mV/m |
1.59 (1.19–2.11) |
Q4: _916.96 mV/m |
1.08 (0.8–1.45) |
Bektas et al. [54] |
2020 |
Turkey |
Cohort |
149 |
Pregnant women after birth, placenta and cord blood samples were collected |
Use of mobile phone and Wi-Fi (2.4 GHz) |
Maternal exposure to mobile phone: Group 1: user mobile phone (N = 48), Group 2: Wi-Fi exposed (N = 17), Group 3: mobile phone plus Wi-Fi (N = 64) vs unexposed group (control) (N = 20) |
DNA damage was detected in lymphocytes of the samples of cord blood with Comet test |
Tail intensity |
Control group: 24.72 ± 2.79 |
5 |
Group 1: 46.13 ± 11.50 |
Group 2: 23.76 ± 4.45 |
Group 3: 46.86 ± 11.47 (p < 0.001) |
Tail movement |
Control group: 41.32 ± 10.09 |
Group 1: 106.95 ± 71.78 |
Group 2: 38.13 ± 7.87 |
Group 3: 127.82 ± 81.01 (p < 0.001) |
Oxidant factors in cord blood |
Protein carbonyl |
Control group: 62.54 ± 16.28 |
Group 1: 82.92 ± 17.01 |
Group 2: 68.46 ± 11.93 |
Group 3: 86.68 ± 13.22 (p < 0.001) |
|
8-Hydroxy-20-deoxyguanosine |
Control group: 81.63 ± 9.87 |
Group 1: 96.11 ± 13.84 |
Group 2: 80.43 ± 11.44 |
Group 3: 99.77 ± 15.12 (p < 0.001) |
Malondialdehyde [53] |
Control group: 10.35 ± 7.86 |
Group 1: 25.45 ± 15.47 |
Group 2: 11.87 ± 7.55 |
Group 3: 27.48 ± 12.03 (p < 0.001) |
Total oxidant status (TOS) |
Control group: 9.08 ± 1.94 |
Group 1: 11.30 ± 2.11 |
Group 2: 10.18 ± 1.86 |
Group 3: 10.96 ± 2.15 (p < 0.001) |
Antioxidant factors in cord blood |
TOS |
Control group: 1.28 ± 0.48 |
Group 1: 0.89 ± 0.377 |
Group 2: 1.09 ± 0.43 |
Group 3: 0.91 ± 0.41 (p < 0.001) |
Ratio of total oxidant to total antioxidant |
Oxidative stress index (OSI) |
Control group: 8.29 ± 3.95 |
Group 1: 14.65 ± 5.61 |
Group 2: 10.45 ± 3.67 |
Group 3: 14.62 ± 7.44 (p < 0.001) |
Bektas et al. [33] |
2018 |
Turkey |
Cohort |
149 |
Pregnant women were divided into three groups based on the duration of mobile phone use per day |
Radiofrequencies (RFs) emitted from mobile phones |
Mother who user mobile phone: Group 1 (2–15 min/day), N = 39, Group 2: (15–60 min/day), N = 37, Group 3: more than 60 min/day, N = 36; control group: nonusers of mobile phone N = 37 |
Biochemical parameters of cord blood |
Aspartate aminotransferase |
Control group: 44.54 ± 19.94 |
4 |
Group 1: 46.61 ± 17.17 |
Group 2: 64.83 ± 18.75 |
Group 3: 75.05 ± 23.39 (p < 0.001 |
Alanine aminotransferase |
Control group: 49.29 ± 28.27 |
Group 1: 42.51 ± 22.28 |
Group 2: 47.81 ± 14.94 |
Group 3: 61.38 ± 31.25, (p < 0.001) |
Lactate dehydrogenase |
Control group: 386.75 ± 147.98 |
Group 1: 765.97 ± 483.77 |
Group 2: 807.10 ± 262.77 |
Group 3: 866.91 ± 279.63, (p < 0.001 |
Creatine kinase |
Control group: 84.18 ± 35.72 |
Group 1: 110.28 ± 95.21 |
Group 2: 172.35 ± 118.73 |
Group 3: 497.88 ± 156.09 (p < 0.001) |
Creatine kinase–myocardial band |
Control group: 67.18 ± 40.91 |
Group 1: 81.69 ± 23.85 |
Group 2: 95.00 ± 29.14 |
Group 3: 127.66 ± 49.53 (p < 0.001) |
C-reactive protein |
Control group: 0.71 ± 0.46 |
Group 1: 0.80 ± 0.38 |
Group 2: 1.01 ± 0.58 |
Group 3: 3.77 ± 2.03 (p < 0.001) |
Troponin T |
Control group: 18.57 ± 4.81 |
Group 1: 18.32 ± 3.54 |
Group 2: 26.16 ± 7.16 |
Group 3: 70.03 ± 15.05 (p < 0.001) |
Uric acid |
Control group: 3.04 ± 0.64 |
Group 1: 3.31 ± 0.68 |
Group 2: 3.53 ± 0.80 |
Group 3: 4.72 ± 1.01 (p < 0.001) |
Platelet |
Control group: 271955.56 ± 70,826 |
Group 1: 283953.97 ± 82,324 |
Group 2: 278397 ± 64,684 |
Group 3: 241356.77 ± 62,525 (p < 0.029) |
Luo et al. [55] |
2013 |
China |
Cohort |
40 |
Pregnant women in gestational age: 50–60 day after 20 min exposure to RF-EMF, were undergoing the induced abortion |
Electro-magnetic wave emitted from cellular telephone (Global System for Mobile communications network; 900 MHz frequency; maximum power < 1 W; specific absorption rate 1.46 W/kg) |
Maternal exposure to EMFs from cell phone (N = 20) vs control group: mother not exposure (N = 20) |
Deferentially expressed proteins profile in chorionic tissues: COMT, Capzb, and antioxidant factor: TXNL-2 |
Capzb |
Control group: 0.67 ± 0.2 |
6 |
Group 1: 1.8 ± 0.23 (p < 0.05) |
COMT |
Control group: 0.3 ± 0.25 |
Group 1: 0.7 ± 0.3 (p < 0.05) |
TXNL2 |
Control group: 1.3 ± 0.35 |
Group 1: 0.9 ± 0.4 (p < 0.05) |
Grufferman et al. [41] |
2009 |
USA |
Case–control |
618 (Case: 311 and control: 309) |
Children under the age of 20 years with and without rhabdomyosarcoma and their mothers |
X-rays examinations |
X-ray examinations in mothers throughout pregnancy vs not examination |
Case rhabdomyosarcoma in children (N = 311); control group (N = 309) |
1.9 (1.1–3.4) |
6 |
X-ray examinations in mothers during first trimester vs not examination |
Case: rhabdomyosarcoma in children (N = 311); control group (N = 309) |
5.7 (1.2–27.8) |
Shu et al. [42] |
2002 |
USA |
Case–control |
3,828 (Case: 1,842 and control: 1,986) |
Children under the age of 15 years with and without ALL and their mothers |
X-rays examinations |
X-ray examinations in mothers throughout pregnancy vs not examination |
Case: childhood ALL (N = 1,809); control group (N = 1,950) |
1 (0.8–1.3) |
5 |
X-ray pelvimetry examinations in mothers throughout pregnancy vs not examination |
Case: childhood ALL (N = 1,804); control group (N = 1,942) |
1.2 (0.8–1.7) |
X-ray examinations of lower abdominal in mothers during preconception vs not examination |
Case: childhood T cell ALL (N = 181); control group (N = 198) |
1.2 (0.7–2.1) |
Stålberg et al. [56] |
2007 |
Sweden |
Case –control |
1,036 (Case: 512 and control: 524) |
Children under the age of 15 years with and without Children Brain tumors and subtypes of brain tumor |
X-rays examinations |
Prenatal abdominal X-ray examination in mothers vs not examination |
Case: childhood all brain tumor (N = 503); control group (N = 512) |
1.02 (0.64–1.62) |
5 |
Prenatal abdominal X-ray examination in mothers vs not examination |
Case: primitive neuro ectodermal tumors (N = 105); control group (N = 512) |
1.88 (0.92–3.83) |